Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome

Annals of Gastroenterology

Volumn 28, Issue 1, 2015, Pages 87-93

  Ghorbani, Shireen ^a   Nejad, Amir ^a   Law, David ^b   Chua, Kathleen S ^a   Amichai, Meridythe M ^a   Pimentel, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Functional GI disorders; Healthy control; Irritable bowel syndrome

Indexed keywords

ARTICLE; BOWEL DISEASE QUESTIONNAIRE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROL GROUP; HUMAN; INTERMETHOD COMPARISON; IRRITABLE COLON; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUESTIONNAIRE; SYSTEMATIC REVIEW; VALIDATION PROCESS;

EID: 84920489030     PISSN: 11087471     EISSN: 17927463     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Schlesselman JJ, Stolley PD. Case-control studies: design, conduct, analysis. Oxford University Press: New York; 1982.
2. Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ 2004;328:1312-1315.
3. Henderson PK, DiPalma JA. Diagnosing irritable bowel syndrome: a changing clinical paradigm. South Med J 2011;104:195-199.
4. Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol 2003;98:789-797.
5. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-177.
6. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23-30.
7. Breslow N. Design and analysis of case-control studies. Annu Rev Public Health 1982;3:29-54.
8. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002;122:1701-1714.
9. Guidelines-Rome III diagnostic criteria for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006;15:301-312.
10. Korkut E, Bektas M, Oztas E, Kurt M, Cetinkaya H, Ozden A. The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. Eur J Intern Med 2010;21:389-392.
11. O’Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002;97:1463-1467.
12. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504-1508.
13. Keohane J, O’Mahony C, O’Mahony L, O’Mahony S, Quigley EM, Shanahan F. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 2010;105:1788, 1789-1794; quiz 1795.
14. Minderhoud IM, Oldenburg B, Wismeijer JA, Van Berge Henegouwen GP, Smout AJPM. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004;49:469-474.
15. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BMR, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009;169:651-658.
16. Longo DL, Fauci AS, Kasper DL, et al. Diarrhea and constipation. In: Harrison’s online featuring the complete contents of Harrison’s Principles of Internal Medicine, 18e.
17. Talley NJ. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990;65:1456-1479.
18. Deiteren A, Camilleri M, Burton D, McKinzie S, Rao A, Zinsmeister AR. Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci 2010;55:384-391.
19. Agrawal A, Houghton LA, Reilly B, Morris J, Whorwell PJ. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit. Am J Gastroenterol 2009;104:1998-2004.
20. Mason HJ, Serrano-Ikkos E, Kamm MA. Psychological morbidity in women with idiopathic constipation. Am J Gastroenterol 2000;95:2852-2857.
21. Rao SSC, Kuo B, McCallum RW, et al. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol 2009;7:537-544.
22. Lu WZ, Song GH, Gwee KA, Ho KY. The effects of melatonin on colonic transit time in normal controls and IBS patients. Dig Dis Sci 2009;54:1087-1093.
23. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis 2009;24:49-55.
24. Abrahamsson H, Ostlund-Lindqvist AM, Nilsson R, Simren M, Gillberg PG. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol 2008;43:1483-1488.
25. Schoepfer AM, Schaffer T, Seibold-schmid B, Muller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008;20:1110-1118.
26. Bharucha AE, Seide BM, Zinsmeister AR, Melton LJ. Insights into normal and disordered bowel habits From bowel diaries. Am J Gastroenterol 2008;103:692-698.
27. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991;32:73-79.
28. Park KS, Ahn SH, Hwang JS, et al. A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients. Dig Dis Sci 2008;53:704-711.
29. Andresen V, Camilleri M, Kim HJ, et al. Is there an association between GNβ3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology 2006;130:1985-1994.
30. Wen-Bin X, Liu YL. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis Sci 2004;49:312-319.
31. Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003;9:2293-2299.
32. Camilleri M, Carlson P, Zinsmeister AR, et al. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol 2009;296:G510-G516.
33. Ragnarsson O, Hallböök G, Bodemar G. Abdominal symptoms and anorectal function in health and irritable bowel syndrome. Scand J Gastroenterol 2001;36:833-842.
34. Saad RJ, Rao SS, Koch KL, et al. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol 2010;105:403-411.
35. Clemens CH, Samsom M, Van Berge Henegouwen GP, Fabri M, Smout AJPM. Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther 2002;16:993-1002.
36. Bohmelt AH. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 2005;67:288-294.
37. Koszycki, D. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls. Psychosom Med 2005;67:590-595.
38. Tousignant-Laflamme T, Goffaux P, Bourgault P, Marchand S. Different autonomic responses to experimental pain in IBS patients and healthy controls. J Clin Gastroenterol 2006;40:814-820.
39. Manabe N, Wong BS, Camilleri M, Burton D, McKinzie S, Zinsmeister AR. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil 2010;22:293-e82.
40. Song GH, Venkatraman V, Ho KY, Chee MWL, Yeoh KG, Wilder- Smith CH. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain 2006;126:79-90.
41. Hellström PM, Näslund W, Edholm T, et al. GLP-1 Suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil 2008;20:649-659.
42. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008;103:958-963.
43. Barkhordari E, Rezaei N, Ansaripour B, et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010;30:74-79.
44. Aichbichler BW, Wenzl HH, Santa Ana CA, Porter JL, Schiller LR, Fordtran JS. A comparison of stool characteristics from normal and constipated people. Dig Dis Sci 1998;43:2353-2362.
45. Bouchoucha MG, Devroede E, Dorval A, Faye A, Arhan P, Arsac M. Different segmental transit times in patients with irritable bowel syndrome and “normal” colonic transit time: is there a correlation with symptoms? Tech Coloproctol 2006;10:287-296.
46. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol 2005;100:2743-2748.
47. Rana SV, Sharma S, Sinha SK, Kaur H, Sikander A, Singh K. Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from North India. Dig Dis Sci 2009;54:132-135.
48. Parodi A, Dulbecco P, Savarino E, et al. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol 2009;43:962-966.
49. Öhman L, Isaksson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 2009;104:1205-1212.
50. Marciani L, Cox EF, Hoad CL, et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology 2010;138:469-477.e1.
51. Heymen S, Maixner W, Whitehead WE, Klatzkin RR, Mechlin B, Light K. Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. Clin J Pain 2010;26:104-109.
52. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007;133:24-33.
53. Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373-382.
54. Róka R, Rosztóczy A, Leveque M, et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:550-555.
55. Kerckhoffs AP, Samsom M, van der Rest ME, et al. Lower bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009;15:2887-2892.
56. Codling C, O’Mahony L, Shanahan F, Quigley F, Marchesi JR. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010;55:392-397.
57. Muller-Lissner SA, Kaatz V, Brandt W, Keller J, Layer P. The perceived effect of various foods and beverages on stool consistency. Eur J Gastroenterol Hepatol 2005;17:109-112.
58. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-1314.
59. Park JH, Baek YH, Park DIL, et al. Analysis of rectal dynamic and static compliances in patients with irritable bowel syndrome. Int J Colorectal Dis 2008;23:659-664.
60. Nozu T, Kudaira M, Kitamori S, Uehara A. Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome. J Gastroenterol 2006;41:217-222.
61. Connell AM, Hilton C, Irvin EG, Lennard-Jones JE, Misiewicz JJ. Variation in bowel habits in two population samples. Br Med J 1965;2:1095-1099.
62. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920-924.
63. McShane RE, McLane AM. Constipation: consensual and empirical validation. Nurs Clin North Am 1985;20:801-808.
64. Pimentel M, Hwang L, Melmed GY, et al. New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy. Dig Dis Sci 2010;55:145-149.